Purpose: Since HCC lesions are generally characterized by lower Hounsfield unit value (HU) values and higher tracer uptake (SUV or Standardized Uptake Values), we intended to determine if normalizing the SUV by the HU, for the lesion and normal liver would improve sensitivity and specificity. Material and Methods: Twenty-three consecutive patients with HCC diagnosed clinically or pathologically underwent C11-Acetate (C11-A) and F18-FDG (FDG) PET/CT imaging before surgery during a 424-day interval. After exclusion of treated or calcified lesions, 44 lesions are included in this study. The original metrics are the maximum SUV (SUVmax) and maximum or average HU (HUmax or HUmean) for lesions and normal liver. For the normal liver, an average SUV (SUVmean) was included. The derived values are the ratios of SUV/HU values. The efficacy is the fraction of outcomes of non-overlapping metrics between lesion and normal liver. Results: For FDG the efficacy is 0.489 for the lesions SUVmax versus normal liver SUVmax. For lesion SUVmax/HUmean versus normal liver SUVmax/HUmax, the efficacy is 1.00. For C11-A the corresponding values are 0.045 and 0.920. Conclusion: Normalizing SUV values for changes in HU values increases the contrast between normal liver and lesions. Analytical fusion can be very effective.
Introduction

FDG PET/CT (Fluorodeoxyglucose Positron Emission Tomography combined
with Computed Tomography) has not been widely used clinically for some cancers such as Hepatocellular Carcinoma (HCC) due to low level of FDG uptake within the lesions, associated with a high false negative rate. has been reported to have higher sensitivity but precise data on tumor size and differentiation are sparse.
Even so, the contrast between FDG and C11-A, across sizes and differentiation is striking. Across sizes, there is an average sensitivity of 0.46 for FDG and 0.79 for C11-A (p < 0.04 in paired two tailed t-test) [1] [2] [3] . The effect of size is difficult to estimate because most authors express the sizes as ranges in arbitrary intervals. Even so, for intervals between 1 and 2 cm diameter, the sensitivity for FDG is 0.174 and for C11-A 0.870 [1] . In another reference [2] , the respective sensitivities are 0.273 and 0.318. At larger sizes, the contrast between FDG and C11-A decreases (0.929 versus 0.952 respectively) [2] .
Differentiation of the tumor also influences the detection rate of FDG but inconsistently: the rate is 0.00 [4] , 0.356 [5] and 0.594 [6] for well-differentiated lesions. For poorly differentiated ones, the rates are 1.0 [4] and 0.895 [6] . With C11-A, the rates are 0.615 for moderately differentiated lesions and 0.848 for poorly differentiated ones [7] .
The comparisons are not very valid because the threshold for positivity is arbitrary. The most common one is a ratio of 1.2 in comparison with the liver SUV or an SUV of 3.0 both for FDG and C11-A [1] [3] [7] . Dominique Delbeke [8] suggested in invited commentary that utilizing both tracer and categorizing positivity by a logical "OR" combination would present an advantage. However, the fractional rate gain of detection is very small, varying from 1.72% to a maximum of 12.7%. This is true for of all lesions [1] [3] and patients [9] . The gain is low because the results of the two procedures are correlated. If they were independent, the gain by adding C11-A to FDG would be 41%
and to add FDG to C11-A would be 5%. As it is, the combination does not increase efficacy perceptibly and would decrease efficiency.
In this paper, we present an analytical fusion approach whose goal is to improve the contrast between lesions and normal liver by utilizing information from the CT part of the PET/CT. This information is the density of the lesions or the normal liver expressed as Hounsfield Units (HU). HCC lesions have generally a lower HU value than normal liver [10] . The lesion SUV would relatively increase by the division by the lesion HU and the normal liver SUV would relatively decrease by a division by the normal liver HU. The operation would result in increased contrast.
Materials and Methods
Patient data are totally masked, including the date of the study, the sex of the patients and age. No patient consent was obtained. On the non-iv-contrast CT scan, the early HCCs are generally iso-dense compared to the normal liver background. As HCC progress, it becomes more hypodense if not fatty [10] . Table 1 ).
The data are restricted to confirmed HCC lesions and normal liver. There is no additional comparison with the uptake in other lesions. Table 1 . Column 1 shows the ratios for the lesions e.g. SUVmax/HUmean is the ratio of the SUVmax over the average lesion HU. Column 2 uses the same code, but includes an average SUV for the normal liver regions. The efficacy is the fraction of the quantitative outcomes without overlap for lesion and normal liver values. 
Results
In general, our data correspond to those in the reviewed literature: If the threshold for the lesions, SUVmax is a SUV of 3.0, the sensitivity for FDG is 0.59 and 0.84 for C11-A. However, if a lesion/normal liver ratio larger than 1.2 is consi- and 2.9 ± 1.5.
To get equal sensitivities for FDG and C11-A, the lesion's FDG SUVmax limit should be lowered to 2.4, and the C11-A max/max lesion to liver ratio should be lowered to 1.18 and for SUVmax/HUmean to 1.00.
The normalization with the mean and maximum HU values has a profound effect for both tracers, but in general, yields better values for FDG (Table 1 ).
Discussion
The imaging detection of HCC is difficult because the intrahepatic lesions are competing with a relatively high liver background. It is noteworthy that the image of the radioisotope distribution is reconstructed with the inclusion of the CT portion of the procedure. However, the CT data seem to be used exclusively either to explain abnormal tracer uptakes by defined anatomical structures, or to detect abnormal structures that can be characterized by the tracer uptake.
Putting strict numerical limits on SUVmax values between normal and abnormal is problematic; the SUV values do not take into account that the distribution of the tracer is also influenced by the presence of competitive avid sites, including the kidneys, other FDG avid lesions and cardiac uptake for FDG. The lesion to liver ratio is in principle not influenced by those factors, but there is no a priori reason to assume that the ratio is independent of the nature of the tracer.
We demonstrate in this paper that using this prior information analytically improves the interpretation in the case of HCC. In general, there is more information in the fusion of images with different modalities or tracers than the purely visual [11] 
Conclusion
Analytical analysis of multiple modality imaging will improve the quality of diagnostic imaging.
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